Onyx maps fresh expansion for SF campus

Fresh from back-to-back regulatory wins for Stivarga and Kyprolis, fast-growing Onyx Pharmaceuticals ($ONXX) is adding a new building with more than 100,000 square feet of space to its South San Francisco campus. The new facility can house up to 300 workers for Onyx, which has been on an expansive roll recently. Alexandria Real Estate Equities will develop the new building for Onyx, which is taking a 10-year lease on the structure. Release

 

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.